06:05:33 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-08-29 Kvartalsrapport 2024-Q2
2024-05-15 Årsstämma 2024
2024-04-30 Bokslutskommuniké 2023
2023-10-11 Extra Bolagsstämma 2023
2023-08-31 Kvartalsrapport 2023-Q2
2023-05-30 Ordinarie utdelning BRAINP 0.00 DKK
2023-05-26 Årsstämma 2023
2023-04-28 Bokslutskommuniké 2022
2022-09-29 Kvartalsrapport 2022-Q2
2022-09-02 Extra Bolagsstämma 2022
2022-05-19 Ordinarie utdelning BRAINP 0.00 DKK
2022-05-18 Årsstämma 2022
2022-04-29 Bokslutskommuniké 2021

Beskrivning

LandDanmark
ListaFirst North Denmark
SektorHälsovård
IndustriVård & Omsorg
Brain+ är verksamma inom läkemedelsbranschen. Bolaget är specialiserade inom forskning och utveckling för behandling av demens och alzheimers. Produktportföljen inkluderar exempelvis kognitiv stimuleringsterapi. Utöver huvudverksamheten erbjuds även service och tillhörande kringtjänster. Verksamheten drivs med störst närvaro inom Europa.
2023-10-11 13:21:57

Copenhagen, Denmark, October 11, 2023 - Brain+ A/S (Nasdaq First North: BRAINP)

On Wednesday, October 11, 2023, at 8:00 am, Brain+ A/S (Nasdaq First North: BRAINP) held an Extraordinary General Meeting.  The meeting was held electronically.

The meeting was convened with the following agenda:

1. Election of chairman of the meeting
2. Election of Anish Shindore as new board member

The Board of Directors proposed that the Chairman of the Board of Directors, Anders Härfstrand was elected chairman of the meeting. The proposal was adopted.

The chairman of the meeting then established that the general meeting was duly convened and quorate with regard to the agenda.

The Board of Directors proposed that Anish Shindore was elected as new member of the board with immediate effect and for a term until Brain+' Annual General Meeting in 2024.

The proposal was adopted by the general meeting.